Ralf Jungmann (ORCID 0000-0003-4607-3312) shows 224 works, ~16,575 citations, and an h-index of 58 in OpenAlex (Semantic Scholar lists h-index 49, 12,014 citations across 148 papers β a typical cross-database discrepancy reflecting coverage differences) . Field-weighted impact is anchored by landmark first- and last-author papers: Multiplexed 3D DNA-PAINT/Exchange-PAINT (Nature Methods 2014, 1,213 citations), the DNA-PAINT protocol (Nature Protocols 2017, 1,169 citations), transient-binding super-resolution on DNA origami (Nano Letters 2010, 961 citations), qPAINT (Nature Methods 2016, 450 citations), and the SMLM primer (Nature Reviews Methods Primers 2021, 1,014 citations) β a portfolio that defines rather than follows the field .
This combinatorial scaling (6 bases β 41 unique barcodes in six imaging rounds) illustrates the author's signature move: converting linear, round-limited workflows into exponentially scaling encodings with measured 94 Β± 4% (origami) and 97 Β± 1% (cells) decoding accuracy, ~2.5 nm localization precision, and open code/data (github.com/jungmannlab/combi-paint) .
The Combi-PAINT preprint reports replicates (n=4), SDs, specificity ratios (20:1), explicit falsification criteria, and no competing interests β hallmarks of high epistemic discipline. Stated blindspots (binder dependence, channel crosstalk, limited tissue generalization) are honestly framed . The 2024 ACT reliability paper shows the same pattern of thorough psychometric rigor (Ξ± = 0.91β0.96, test-retest r = 0.61β0.69) but transparently reports null validity associations (|r| β€ 0.11, non-significant after Bonferroni) β reporting negative results honestly rather than overclaiming . Caveat: author-name disambiguation is imperfect; the ACT paper's 'Jungmann' may be a different individual from Ralf Jungmann, so it should not be weighted heavily in this review.
Strengths concentrate in method engineering; biological discovery papers (e.g., TREM2-mediated synapse integration, centrosome proteomics) are mostly collaborative applications of his tools, so independent biological hypothesis-testing depth is less demonstrable. Recent citation velocity has slowed (2024: 340; 2025: 114 per OpenAlex), though 2026 works remain too new to judge. No major integrity concerns surfaced in the supplied records.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.